{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:19:54Z","timestamp":1790770794667,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cardiovascularpathology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.carpath.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:38:29Z","timestamp":1517560709000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Pathogenesis of aortic wall complications in Marfan syndrome"],"prefix":"10.1016","volume":"33","author":[{"given":"Nimrat","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"Gittenberger-de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.carpath.2018.01.005_bb0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.carpath.2018.01.005_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ymgme.2012.07.023","article-title":"Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases","volume":"107","author":"Davis","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.carpath.2018.01.005_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00018-016-2324-9","article-title":"Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall","volume":"74","author":"Perrucci","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.carpath.2018.01.005_bb0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/302582","article-title":"Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes","volume":"65","author":"Schrijver","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1172\/JCI117298","article-title":"Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms","volume":"94","author":"Aoyama","year":"1994","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.carpath.2018.01.005_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddg081","article-title":"Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders","volume":"12","author":"Whiteman","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.carpath.2018.01.005_bb0035","first-page":"Ii329","article-title":"Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm","volume":"108","author":"Nataatmadja","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carpath.2018.01.005_bb0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1097-218","article-title":"Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome","volume":"17","author":"Pereira","year":"1997","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0045","first-page":"803","article-title":"Abnormal fibrillin metabolism in bovine Marfan syndrome","volume":"142","author":"Potter","year":"1993","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/physiolgenomics.00111.2010","article-title":"Vascular smooth muscle phenotypic diversity and function","volume":"42a","author":"Fisher","year":"2010","journal-title":"Physiol Genomics"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00380-015-0703-z","article-title":"Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?","volume":"31","author":"Grewal","year":"2016","journal-title":"Heart Vessels"},{"issue":"25","key":"10.1016\/j.carpath.2018.01.005_bb0065","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jacc.2009.12.068","article-title":"Bicuspid aortic valve disease","volume":"55","author":"Siu","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9149(03)00462-4","article-title":"Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves","volume":"92","author":"Ferencik","year":"2003","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.carpath.2018.01.005_bb0075","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.amjcard.2006.04.022","article-title":"Progression of aortic dilation in children with a functionally normal bicuspid aortic valve","volume":"98","author":"Beroukhim","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.carpath.2018.01.005_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2013-304920","article-title":"Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy","volume":"100","author":"Detaint","year":"2014","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.carpath.2018.01.005_bb0085","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jtcvs.2014.01.027","article-title":"Ascending aorta dilation in association with bicuspid aortic valve: a maturation defect of the aortic wall","volume":"148","author":"Grewal","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ejcts\/ezu319","article-title":"Bicuspid aortic valve: phosphorylation of c-Kit and downstream targets are prognostic for future aortopathy","volume":"46","author":"Grewal","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0095","first-page":"207","article-title":"Cardiac myofibroblasts express alpha smooth muscle actin during right ventricular pressure overload in the rabbit","volume":"139","author":"Leslie","year":"1991","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1556-4029.2011.01807.x","article-title":"\"Grown-up\" congenital heart disease and sudden death in a medical examiner's population","volume":"56","author":"Hamilton","year":"2011","journal-title":"J Forensic Sci"},{"issue":"11","key":"10.1016\/j.carpath.2018.01.005_bb0105","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/ATVBAHA.110.209460","article-title":"Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging","volume":"30","author":"Olive","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"20","key":"10.1016\/j.carpath.2018.01.005_bb0110","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"Ragnauth","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.carpath.2018.01.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023975","article-title":"Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonates","volume":"6","author":"Bokenkamp","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.carpath.2018.01.005_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIR.0000000000000331","article-title":"Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"133","author":"Hiratzka","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.carpath.2016.03.002","article-title":"Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria","volume":"25","author":"Halushka","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2018.01.005_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carpath.2017.05.008","article-title":"Histopathologic differences partially distinguish syndromic aortic diseases","volume":"30","author":"Waters","year":"2017","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00380-015-0703-z","article-title":"Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?","volume":"31","author":"Grewal","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carpath.2018.01.005_bb0140","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/hmg\/4.suppl_1.1799","article-title":"Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders","volume":"4","author":"Dietz","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"Pt 1","key":"10.1016\/j.carpath.2018.01.005_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/jcs.106.1.167","article-title":"Synthesis and assembly of fibrillin by fibroblasts and smooth muscle cells","volume":"106","author":"Kielty","year":"1993","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0150","first-page":"22","article-title":"Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders","volume":"21","author":"Milewicz","year":"1994","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1172\/JCI115589","article-title":"Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts","volume":"89","author":"Milewicz","year":"1992","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM199007193230303","article-title":"Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome","volume":"323","author":"Hollister","year":"1990","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.carpath.2018.01.005_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12471-014-0576-2","article-title":"Normal and abnormal development of the aortic wall and valve: correlation with clinical entities","volume":"22","author":"Grewal","year":"2014","journal-title":"Neth Heart J"},{"issue":"6","key":"10.1016\/j.carpath.2018.01.005_bb0170","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1172\/JCI117251","article-title":"Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells","volume":"93","author":"Kagami","year":"1994","journal-title":"J Clin Invest"},{"issue":"12 Suppl. 1","key":"10.1016\/j.carpath.2018.01.005_bb0175","doi-asserted-by":"crossref","first-page":"I282","DOI":"10.1161\/hc37t1.094856","article-title":"Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome","volume":"104","author":"Nagashima","year":"2001","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.carpath.2018.01.005_bb0180","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.RES.0000126897.41658.81","article-title":"Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line","volume":"94","author":"Chen","year":"2004","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0185","first-page":"11","article-title":"Transforming growth factor-\u03b2 and smooth muscle differentiation","volume":"3","author":"S.-Y.C.","year":"2012","journal-title":"World J Biol Chem"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/cvr\/cvq230","article-title":"TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections","volume":"88","author":"Inamoto","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"20","key":"10.1016\/j.carpath.2018.01.005_bb0195","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/heartjnl-2013-305132","article-title":"Surgical management of aortic root disease in Marfan syndrome and other congenital disorders associated with aortic root aneurysms","volume":"100","author":"Treasure","year":"2014","journal-title":"Heart"},{"issue":"26","key":"10.1016\/j.carpath.2018.01.005_bb0200","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carpath.2018.01.005_bb0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations","volume":"10","author":"Gambarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome","volume":"103","author":"Detaint","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.carpath.2018.01.005_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-6215-11-3","article-title":"Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial","volume":"11","author":"Radonic","year":"2010","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2010.12.070","article-title":"The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with beta-blockers","volume":"157","author":"Moberg","year":"2012","journal-title":"Int J Cardiol"},{"issue":"45","key":"10.1016\/j.carpath.2018.01.005_bb0225","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.carpath.2018.01.005_bb0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.carpath.2018.01.005_bb0235","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/chd.12184","article-title":"The effect of angiotensin-converting enzyme inhibitors on the rate of ascending aorta dilation in patients with bicuspid aortic valve","volume":"10","author":"Ohnemus","year":"2015","journal-title":"Congenit Heart Dis"},{"issue":"5","key":"10.1016\/j.carpath.2018.01.005_bb0240","doi-asserted-by":"crossref","DOI":"10.15761\/IMM.1000308","article-title":"The effects of hemodynamics on the inner layers of the aortic wall in patients with a bicuspid aortic valve","volume":"4","author":"Grewal","year":"2017","journal-title":"Integr Mol Med"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880717303381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880717303381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T16:52:06Z","timestamp":1660409526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880717303381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":48,"alternative-id":["S1054880717303381"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2018.01.005","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of aortic wall complications in Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}